Decheng Capital China Life Sciences USD Fund III, L.P. sold $36k of BYSI
owner at BeyondSpring Inc.. 20,200 shares at an average of $1.78, traded Oct 3, 2025, filed Oct 7, 2025.
Score components
- +12Role10% owner
- +6Trade size$36k at market
- 0Share of holdings soldSold 1.1% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +7.0%, 3m -16.4%, 6m -4.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001231919-25-000292, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 3, 2025 | SOpen-market sale Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P. | -600 | $1.76 | $1,056 | 1,837,496 | Oct 7, 2025 |
| Oct 6, 2025 | SOpen-market sale Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P. | -17,500 | $1.78 | $31k | 1,819,996 | Oct 7, 2025 |
| Oct 7, 2025 | SOpen-market sale Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P. | -2,100 | $1.79 | $3,759 | 1,817,896 | Oct 7, 2025 |
Related signals
Other insiders at BeyondSpring Inc. and this insider’s other filings.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.